Initially identified as a marker of ovarian cancer, CD47 was later found to be ubiquitous in different mammalian cell types, leading to a paradigm shift in cancer immunotherapy (Liu et al., 2023a, 2023b). The gene discussed is CD47; the disease is cancer.